Biotech developing peptide treatments for neurodegenerative diseases
| Date | Round | Amount |
|---|---|---|
| Mar 2023 | Series A Teitur Trophics raised EUR28M Series A co-led by Sunstone Life Science Ventures and Sound Bioventures, with Industrifonden, Innovestor and P53 Invest. | $28M |
| Feb 2023 | Series A Aarhus biotech Teitur Trophics raised EUR28M Series A co-led by Sunstone and Sound Bioventures. | $30.2M |